Results 11 to 20 of about 984,572 (204)
Afamin and adropin in patients with alcohol-induced liver cirrhosis [PDF]
The aim of the study was to determine serum concentrations of afamin and adropin in patients with alcoholic liver cirrhosis and to define their correlation with the stage of disease. The study included 99 patients with alcoholic cirrhosis from the region
Andrzej Prystupa +8 more
doaj +2 more sources
Elevated endotoxin levels in non-alcoholic fatty liver disease [PDF]
Background: Emerging data indicate that gut-derived endotoxin may contribute to low-grade systemic inflammation in insulin resistant states. This study aimed to examine the importance of serum endotoxin and inflammatory markers in non-alcoholic fatty ...
Ashour, E. +70 more
core +1 more source
Intrarenal Resistance Index as a Prognostic Parameter in Patients with Liver Cirrhosis Compared with Other Hepatic Scoring Systems [PDF]
Background and Aims: Patients with advanced liver cirrhosis who develop renal dysfunction have a poor prognosis. Elevated intrarenal resistance indices (RIs) due to renal vascular constriction have been described before in cirrhotic patients.
Kaiser, C. +7 more
core +1 more source
Dose adaptation of drugs in patients with liver disease [PDF]
A detailed introduction into the topic was obtained by developing a German-language online course named “Dose adjustment in Patients with Liver Disease” for the “Swiss Virtual Campus” in collaboration with PNN AG, a spin-off company of the ETH Zurich.
Schlatter-Häner, Chantal
core +1 more source
EXPERIMENTAL ALCOHOLIC CIRRHOSIS OF THE LIVER [PDF]
Ever since the experimental method has been used in pathology numerous attempts have been made to show the connection between cirrhosis of the liver as often seen in "steady drinkers" and alcohol as the causative factor. In this experimental work alcohol has been used subcutaneously, intravenously, by inhalation, and fed by mouth.
openaire +1 more source
Background Liver diseases are suspected risk factors for intracerebral haemorrhage (ICH). We conducted a population-based case-control study to examine risk of ICH among hospitalised patients with liver cirrhosis and other liver diseases. Methods We used
Vilstrup Hendrik +6 more
doaj +1 more source
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease : a systematic review [PDF]
Non-alcoholic fatty liver disease (NAFLD) is closely linked with obesity and the prevalence of NAFLD is about 17% to 33% in the Western world. There is a strong association of NAFLD with insulin resistance and, hence, insulin sensitisers have been tried.
C Clar +21 more
core +1 more source
In alcoholic liver cirrhosis, normal liver cells are replaced by scar tissue (fibrosis). Liver fibrosis is a dynamic process in which activated hepatic stellate cells are involved in the synthesis of matrix proteins and the regulation of matrix ...
Andrzej Prystupa +5 more
doaj +3 more sources
Serum microRNA-122 predicts survival in patients with liver cirrhosis [PDF]
Background: Liver cirrhosis is associated with high morbidity and mortality. MicroRNAs (miRs) circulating in the blood are an emerging new class of biomarkers.
Stefan Zeuzem +17 more
core +2 more sources
Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis [PDF]
In 11 patients with decompensated cirrhosis and deteriorating renal function, the effect of the vasoconstrictor substance 8-ornithin vasopressin (ornipressin; POR 8; Sandoz, Basel, Switzerland) on renal function, hemodynamic parameters, and humoral ...
Reither, H. +8 more
core +1 more source

